Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles

Early antibody therapy can prevent severe SARS-CoV-2 infection (COVID-19). However, the effectiveness of COVID-19 convalescent plasma (CCP) therapy in treating severe COVID-19 remains inconclusive. To test a hypothesis that some CCP units are associated with a coagulopathy hazard in severe disease t...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Svenja Weiss, Hung-Mo Lin, Eric Acosta, Natalia L. Komarova, Ping Chen, Dominik Wodarz, Ian Baine, Ralf Duerr, Ania Wajnberg, Adrian Gervais, Paul Bastard, Jean-Laurent Casanova, Suzanne A. Arinsburg, Talia H. Swartz, Judith A. Aberg, Nicole M. Bouvier, Sean T.H. Liu, Raymond A. Alvarez, Benjamin K. Chen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Clinical Investigation 2025-05-01
סדרה:	The Journal of Clinical Investigation
נושאים:	COVID-19 Immunology
גישה מקוונת:	https://doi.org/10.1172/JCI181136
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!